|
|
Expression of long noncoding RNA-AWPPH in the tissues of endometrial cancer patients and its relationship with pathological parameters and prognosis |
WANG Bing1 LIN Lin2 GU Te3 |
1.Out-patient Operating Room, Dalian Women and Children Medical Center (Group), Liaoning Province, Dalian 116021, China;
2.Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Dalian Medical University, Liaoning Province, Dalian 116021, China;
3.Ward Two, Department of Gynaecology, Dalian Women and Children Medical Center (Group), Liaoning Province, Dalian 116021, China |
|
|
Abstract Objective To investigate the expression of long noncoding RNA (lncRNA)-AWPPH in the tissues of endometrial cancer (EC) patients and its relationship with pathological parameters and prognosis. Methods A total of 93 EC patients admitted to Dalian Women and Children Medical Center (Group) from January 2017 to December 2018 were selected. LncRNA-AWPPH expression in EC tissues and paracancer tissues was detected by qRT-PCR, and the relationship between the expression and the pathological characteristics of EC was analyzed. According to the mean value of lncRNA-AWPPH expression, patients were divided into high lncRNA-AWPPH expression group (43 cases) and low lncRNA-AWPPH expression group (50 cases). Survival curves were used to analyze the three-year postoperative survival of the two groups. Results LncRNA-AWPPH expression in EC tissues was higher than that in paracancer tissues (P<0.05). LncRNA-AWPPH expression in EC patients with different Federation Infernational of Gynecology and Obstetrics stages, depth of muscle infiltration, histological stages, lymphatic vascular space infiltration, and lymph node metastasis were statistically significant (P<0.05). The three-year cumulative survival rate of high lncRNA-AWPPH expression group was lower than that of low lncRNA-AWPPH expression group, and the difference was statistically significant (P<0.05). Conclusion LncRNA-AWPPH expression is up-regulated in EC tissues, and the survival of patients with high lncRNA-AWPPH expression is poor, which is worthy of further clinical study.
|
|
|
|
|
[1] 中国抗癌协会妇科肿瘤专业委员会.子宫内膜癌诊断与治疗指南(第四版)[J].中国实用妇科与产科杂志,2018, 34(8):880-886.
[2] Wright JD,Matsuo K,Huang Y,et al. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines [J]. Obstet Gynecol,2019,134(1):49-57.
[3] Ferlita A,Battaglia R,Andronico F,et al. Non-Coding RNAs in Endometrial Physiopathology [J]. Int J Mol Sci,2018,19(7):2120.
[4] Liu H,Wan J,Chu J. Long non-coding RNAs and endometrial cancer [J]. Biomed Pharmacother,2019,119:109396.
[5] 袁霜,王丽华.基于内源性竞争性网络的Ⅰ型、Ⅱ型子宫内膜癌关键长非编码RNA和微小RNA分析[J].检验医学,2021,36(5):535-543.
[6] 建方方,车晓霞,冯炜炜.子宫内膜癌中长链非编码RNA表达谱的生物信息学分析[J].上海交通大学学报(医学版),2020,40(6):768-775.
[7] Zhao X,Liu Y,Yu S. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker [J]. Biochim Biophys Acta Mol Basis Dis,2017,1863(7):1805-1816.
[8] Li X,Song F,Sun H. Long non-coding RNA AWPPH interacts with ROCK2 and regulates the proliferation and apoptosis of cancer cells in pediatric T-cell acute lymphoblastic leukemia [J]. Oncol Lett,2020,20(5):239.
[9] Ding W,Wu D,Ji F,et al. Inhibition of long non-coding RNA- AWPPH decreases osteosarcoma cell proliferation,migration and invasion [J]. Oncol Lett,2019,18(5):5055-5062.
[10] Matsuo K,Machida H,Mandelbaum RS,et al. Validation of the 2018 FIGO cervical cancer staging system [J].Gynecol Oncol,2019,152(1):87-93.
[11] Bray F,Ferlay J,Soerjomataram I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin,2018,68(6):394-424.
[12] 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.
[13] Nair L,Chung H,Basu U. Regulation of long non-coding RNAs and genome dynamics by the RNA surveillance machinery [J]. Nat Rev Mol Cell Biol,2020,21(3):123-136.
[14] Zhang W,Tang G,Zhou S,et al. LncRNA-miRNA interaction prediction through sequence-derived linear neighborhood propagation method with information combination [J]. BMC Genomics,2019,20(S11):946.
[15] 李文龙,林晓雨,李小文,等.子宫内膜癌中的lncRNA-miRNA-mRNA ceRNA网络的整合分析[J].生命的化学,2021,41(2):379-386.
[16] 徐海霞,伊碧霞,胡娥.干扰DBH-AS1上调miR-149抑制子宫内膜癌细胞增殖、迁移与侵袭[J].中国优生与遗传杂志,2021,29(11):1538-1543.
[17] Li L,Kou J,Zhong B. Up-regulation of long non-coding RNA AWPPH inhibits proliferation and invasion of gastric cancer cells via miR-203a/DKK2 axis [J]. Hum Cell,2019,32(4):495-503.
[18] Tang L,Wang T,Zhang Y,et al. Long Non-Coding RNA AWPPH Promotes Postoperative Distant Recurrence in Resected Non-Small Cell Lung Cancer by Upregulating Transforming Growth Factor beta 1(TGF-β1)[J]. Med Sci Monit,2019,25:2535-2541.
[19] Li C,Wang F,Wei B,et al. LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt/β-catenin pathway through modulating miR-93-3p/FZD7 axis [J]. Biochem Biophys Res Commun,2019,514(3):1017-1022.
[20] Chen JJ,Xiao ZJ,Meng X,et al. MRP4 sustains Wnt/ β-catenin signaling for pregnancy,endometriosis and endometrial cancer [J]. Theranostics,2019,9(17):5049-5064.
[21] 申晓畅,孙一卿,颜磊,等.miR1290在子宫内膜癌发生发展中的作用及其机制[J].中华肿瘤杂志,2022,44(2):130-138.
[22] 林娟,闫咨儒,高艳宇.miR-497-5p靶向调控Wnt3a/ β-catenin信号通路抑制子宫内膜癌进展的体外细胞实验[J].中国优生与遗传杂志,2021,29(3):345-349.
[23] 朱丽娟,王爱华,段晓艳.长链非编码RNA AWPPH调控微RNA-383-5p对子宫内膜癌细胞增殖、侵袭和迁移的影响及作用机制研究[J].中华生物医学工程杂志,2019,25(6):667-672.
[24] Azarbarzin S,Hosseinpour-Feizi MA,Banan Khojasteh SM,et al. MicroRNA-383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1 [J]. Life Sci,2021,267:118939.
[25] Hu Y,Ma Y,Liu J,et al. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis [J]. BMC Cancer,2019,19(1):1157. |
|
|
|